These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 33895826)

  • 1. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.
    Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV
    J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
    Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
    Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V; Mark H W; Jane F
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides (Clostridium) difficile in adults with diarrhoea in Vietnam.
    Khun PA; Phi LD; Bui HTT; Collins DA; Riley TV
    Anaerobe; 2023 Jun; 81():102741. PubMed ID: 37244476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021.
    Tsai CS; Lu PL; Lu MC; Hsieh TC; Chen WT; Wang JT; Ko WC
    J Microbiol Immunol Infect; 2024 Apr; 57(2):320-327. PubMed ID: 38135646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides (Clostridium) difficile isolated from paediatric patients in Western Australia 2019-2020.
    Perumalsamy S; Lim SC; Riley TV
    Pathology; 2022 Jun; 54(4):460-465. PubMed ID: 35125203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization of, and Antimicrobial Resistance in,
    Imwattana K; Putsathit P; Knight DR; Kiratisin P; Riley TV
    Microb Drug Resist; 2021 Nov; 27(11):1505-1512. PubMed ID: 33956520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Lim SC; Androga GO; Knight DR; Moono P; Foster NF; Riley TV
    Int J Antimicrob Agents; 2018 Sep; 52(3):411-415. PubMed ID: 29802886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
    Gargis AS; Karlsson M; Paulick AL; Anderson KF; Adamczyk M; Vlachos N; Kent AG; McAllister G; McKay SL; Halpin AL; Albrecht V; Campbell D; Korhonen LC; Elkins CA; Rasheed JK; Guh AY; McDonald LC; Lutgring JD;
    Clin Infect Dis; 2023 Mar; 76(5):890-896. PubMed ID: 36208202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridioides (Clostridium) difficile in children with diarrhoea in Vietnam.
    Khun PA; Phi LD; Pham PT; Thu Nguyen HT; Huyen Vu QT; Collins DA; Riley TV
    Anaerobe; 2022 Apr; 74():102550. PubMed ID: 35331913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey].
    Sayın E; Bilgin H; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.